Accenture (NYSE:ACN) said today that it inked a five-year deal with Roche (OTC:RHHBY) to incorporate its analytics platform into Roche’s digital diabetes management system.
According to the deal, Roche’s new digital “diabetes ecosystem” will be built on the Accenture Intelligent Patient Platform. The system reportedly allows Roche to collect and analyze data from diabetes patients in the U.S., Europe and Asia in an effort to develop more personalized care models.
Get the full story at our sister site, Drug Delivery Business News.
The post Roche taps Accenture’s analytics tech for digital diabetes management appeared first on MassDevice.
from MassDevice http://ift.tt/2tCSqiw
Cap comentari:
Publica un comentari a l'entrada